1,6-Bis(acryloyloxy)-2,2,3,3,4,4,5,5-octafluorohexane (stabilized with MEHQ)>90.0%(GC)5g

(4S,4'S)-2,2'-(1,3-BIS(4-(TERT-BUTYL)PHENYL)PROPANE-2,2-DIYL)BIS(4-BENZYL-4,5-DIHYDROOXAZOLE), 95%, 100mg

5-Bromo-1,3-dihydrobenzoimidazol-2-one, 95.0%, 5g

3-Methylmorpholine hydrochloride, 95.0%, 1g

2-Chloronaphthalene, 95.0%, 250mg

2-Chloro-3-phenylquinoxaline>98.0%(GC)1g

2-Hydroxy-5-nitropyrimidine, 95.0%, 5g

8-Iodo-naphthalen-1-ylamine, 96%, 500mg

Tert-butyl (2R,4R)-2-cyano-4-hydroxypyrrolidine-1-carboxylate, 97%, 250mg

4-(2,5-dimethoxyphenyl)-6-imino-3-(naphthalen-2-yl)-1H,4H,5H,6H-pyrano[2,3-c]pyrazole-5-carbonitrile, 50mg

{6-[(4-Methoxyphenyl)methoxy]-5-(trifluoromethyl)pyridin-3-yl}boronic acid, 98%, 1g

Diammonium Ethylenediaminetetraacetate Monohydrate>98.0%(N)(T)500g

(R)-methyl 5-((S)-1,1-dimethylethylsulfinamido)-5-(4-morpholinophenyl)-3-oxo-5-(thiophen-3-yl)pentanoate, 97%, 10mg